@amissa.com

Amissa develops AI-powered software platforms for investment research and healthcare analytics, with core capabilities in natural language processing and alternative data analysis. The company's flagship product processes financial documents and unstructured market data to surface emerging trends for hedge funds and institutional investors. Financial services clients use the platform to analyze sentiment signals and market indicators across millions of documents simultaneously. The healthcare division of Amissa focuses on integrating data from consumer wearables and remote monitoring devices into clinical workflows. The platform aggregates patient data from connected health devices to enable early intervention protocols and reduce preventable hospitalizations. Healthcare providers use these analytics tools to transition toward preventative care models based on continuous patient monitoring. Amissa maintains dual headquarters in Boston and Singapore, serving institutional clients in financial services and healthcare sectors globally. The company holds patents for its natural language processing technology and maintains partnerships with major electronic health record vendors. Amissa's solutions are currently deployed at multiple hedge funds, asset management firms, and integrated health systems.